Clinical studies among a variety of patient populations including those with DM, obesity, and stroke have successfully used ISI to evaluate a change in insulin sensitivity after undergoing drug treatment [25-29]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.